Latest News about obesity
Recent news which mentions obesity
Trending billionaire and celebrity GLP-1 weight loss drugs are about to enter more American homes
January 20, 2023
From CNBC.com News
From Benzinga
Short Bits for November
November 30, 2022
From Stock Gumshoe
Banning KFC, McDonald's Near Schools — How Western Australia Plans To Tackle Obesity
November 08, 2022
From Benzinga
2 Biotechs with a possible obesity drug patent??
June 12, 2022
From Stock Gumshoe
From Benzinga
Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity
January 31, 2022
Tickers
ALT
From Benzinga
Novo Nordisk Shares Slump As Wegovy Hits US Supply Issues; Deutsche Bank Downgrades
December 20, 2021
Tickers
NVO
From Benzinga
European Authorities Recommend Approval Of Wegovy For Obesity
November 11, 2021
Tickers
NVO
From Benzinga
H.C. Wainwright Sees Buying Opportunity In This Biotech Stock Sell Off
September 28, 2021
Tickers
ALT
From Benzinga
See Why Altimmune Stock Plunged After Obesity Trial Data
September 28, 2021
Tickers
ALT
From Benzinga
Oviva grabs $80M for app-delivered healthy eating programs
September 01, 2021
Tickers
TC
From TechCrunch
Rhythm Pharma's Imcivree Gets European Approval For Obesity, Control of Hunger Associated With Genetic Mutations
July 23, 2021
Tickers
RYTM
From Benzinga
FDA-Approved Weight Loss Drug Plenity's Parent Announces SPAC Deal: What Investors Should Know
July 19, 2021
From Benzinga
Switch raises $20M for a personalized engagement system designed to boost health outcomes
July 19, 2021
Tickers
TC
From TechCrunch
9 Meters Biopharma Acquires Anti-GIP Monoclonal Antibody For Obesity-Related Disorders
July 19, 2021
Tickers
NMTR
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.